PRDM1 and neoplasm: Finally, we determined what extent disruptions of Treg/TFR suppressive activity by a specific deletion of Blimp1 could impact on the tumor by analyzing gene expression of sorted CD45− cells using the NanoString PanCancer Immune Profiling Panel (Fig. 8a and Additional file 3e).